What's happening to Buffett's Tech investment, IBM?! Check out our Report to see our take on its valuation! HIDE

Neostem (NBS)

Add to Watchlists
Create an Alert
5.27 +0.04  +0.76% NASDAQ Oct 23, 8:00PM BATS Real time Currency in USD
View Full Chart
NBS Price Chart
View All Events

NBS Events

Date Type Description
10/28/2013 Dividends Amount: 0.0323, Declared Date: Sep 21 2013, Pay Date: Nov 22 2013
View All Performance Charts

NBS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Neostem is down 23.59% over the last year vs S&P 500 Total Return up 14.03%, ARCA biopharma down 26.62%, and Xencor up N/A.

Get Quote for

Portfolio Strategies Featuring NBS

Did Neostem make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NBS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.neostem.com
  • IR Website: http://www.neostem.com/investors/overview/
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Neostem Inc is a biopharmaceutical company that develops novel proprietary cell therapy products. It is engaged in the preservation & enhancement of human health through the development of cell based therapeutics that prevent, treat or cure disease.

NBS Excel Add-In Codes

  • Name: =YCI("NBS","name")
  • Description: =YCI("NBS","description")
  • Sector: =YCI("NBS","sector")
  • Industry: =YCI("NBS","industry")
  • Est. Current Fiscal Year End: =YCI("NBS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.